Gaurav Aggarwal

Insider Reports History

Entity
Individual
Location
C/O Panorama Capital, 2440 Sand Hill Road, Suite 302, Menlo Park, CA
Signature
/s/ Scott A. Samuels for Gaurav Aggarwal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gaurav Aggarwal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Unicycive Therapeutics, Inc. Director Common Stock 3.47M $2.86M $0.83 Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.
GERON CORP Director Common Stock 1.97K $4.49K $2.28 Dec 29, 2023 Direct
Unicycive Therapeutics, Inc. Director Tranche C Warrants (right to buy) 18.6M Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.
Unicycive Therapeutics, Inc. Director Series A-2 Preferred Stock 13.4M Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.
Unicycive Therapeutics, Inc. Director Tranche A Warrants (right to buy) 12.8M Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.
Unicycive Therapeutics, Inc. Director Tranche B Warrants (right to buy) 11.6M Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.
GERON CORP Director Stock Option (right to buy) 180K May 9, 2024 Direct
Unicycive Therapeutics, Inc. Director Stock Options 180K Sep 5, 2023 Direct
Unicycive Therapeutics, Inc. Director Series A-1 Convertible Preferred Stock 8.08K Mar 8, 2023 By Vivo Opportunity Fund Holdings, L.P.
Sierra Oncology, Inc. Director Common Stock 0 $55.00 Jul 1, 2022 By: Vivo Opportunity Fund Holdings, L.P.
Sierra Oncology, Inc. Director Series A Warrant 0 Jul 1, 2022 By: Vivo Opportunity Fund Holdings, L.P.
Sierra Oncology, Inc. Director Series B Warrant (Right to Purchase) 0 Jan 26, 2022 By Vivo Opportunity Fund, L.P.
Sierra Oncology, Inc. Director Stock Option (right to buy) 0 Jul 1, 2022 Direct
Unicycive Therapeutics, Inc. Director Series A-1 Preferred Stock 0 Jul 11, 2023 By Vivo Opportunity Fund Holdings, L.P.

Insider Reports Filed by Gaurav Aggarwal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GERN GERON CORP May 9, 2024 1 $0 4 May 10, 2024 Director
GERN GERON CORP Dec 29, 2023 1 $0 4 Jan 3, 2024 Director
GERN GERON CORP Nov 26, 2023 1 $0 4 Nov 28, 2023 Director
GERN GERON CORP Nov 26, 2023 0 $0 3 Nov 28, 2023 Director
UNCY Unicycive Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 Director
UNCY Unicycive Therapeutics, Inc. Jul 11, 2023 6 -$8.08M 4 Jul 13, 2023 Director
UNCY Unicycive Therapeutics, Inc. Mar 8, 2023 1 $8.08M 4 Mar 9, 2023 Director
UNCY Unicycive Therapeutics, Inc. Mar 8, 2023 0 $0 3 Mar 8, 2023 Director
SRRA Sierra Oncology, Inc. Jul 1, 2022 5 -$150M 4 Jul 1, 2022 Director
SRRA Sierra Oncology, Inc. Jan 31, 2022 1 $21.6M 4 Jan 31, 2022 Director, 10%+ Owner
SRRA Sierra Oncology, Inc. Jan 26, 2022 2 -$12.9M 4 Jan 28, 2022 Director, 10%+ Owner
SRRA Sierra Oncology, Inc. Jun 8, 2021 1 $0 4 Jun 9, 2021 Director, 10%+ Owner